Search

Author/Creator Gore, Lia

1. A multi‐center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors1. Issue 2 (28th September 2012)

Authors:
Macy, Margaret E.; Duncan, Tracey; Whitlock, James; Hunger, Stephen P.; Boklan, Jessica; Narendren, Aru; Herzog, Cynthia; Arceci, Robert J.; Bagatell, Rochelle; Trippett, Tanya; Christians, Uwe; Rolla, Katherine; Ivy, S. Percy; Gore, Lia
Journal:
Pediatric blood & cancer
Issue:
Volume 60:Issue 2(2013:Feb.)
Page Start:
230
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high‐grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study. Issue 11 (24th May 2017)

Authors:
Macy, Margaret E.; Kieran, Mark W.; Chi, Susan N.; Cohen, Kenneth J.; MacDonald, Tobey J.; Smith, Amy A.; Etzl, Michael M.; Kuei, Michele C.; Donson, Andrew M.; Gore, Lia; DiRenzo, Jennifer; Trippett, Tanya M.; Ostrovnaya, Irina; Narendran, Aru; Foreman, Nicholas K.; Dunkel, Ira J.
Journal:
Pediatric blood & cancer
Issue:
Volume 64:Issue 11(2017)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A phase 1 study of the CXCR4 antagonist plerixafor in combination with high‐dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10‐03). Issue 8 (14th April 2017)

Authors:
Cooper, Todd M.; Sison, Edward Allan Racela; Baker, Sharyn D.; Li, Lie; Ahmed, Amina; Trippett, Tanya; Gore, Lia; Macy, Margaret E.; Narendran, Aru; August, Keith; Absalon, Michael J.; Boklan, Jessica; Pollard, Jessica; Magoon, Daniel; Brown, Patrick A.
Journal:
Pediatric blood & cancer
Issue:
Volume 64:Issue 8(2017)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low‐grade glioma. Issue 2 (2nd November 2020)

Authors:
Wright, Karen D.; Yao, Xiaopan; London, Wendy B.; Kao, Pei‐Chi; Gore, Lia; Hunger, Stephen; Geyer, Russ; Cohen, Kenneth J.; Allen, Jeffrey C.; Katzenstein, Howard M.; Smith, Amy; Boklan, Jessica; Nazemi, Kellie; Trippett, Tanya; Karajannis, Matthias; Herzog, Cynthia; Destefano, Joseph; Direnzo, J...
Journal:
Pediatric blood & cancer
Issue:
Volume 68:Issue 2(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A prospective survey study of lower urinary tract dysfunction in childhood cancer survivors after vincristine and/or doxorubicin chemotherapy. Issue 10 (10th July 2021)

Authors:
Hecht, Sarah L.; Quach, Alan; Gao, Dexiang; Brazell, Andrew; Beltran, Gemma; Holbrook, Sheryl; Gore, Lia; Iguchi, Nao; Malykhina, Anna; Wilcox, Duncan; Cost, Nicholas G.
Journal:
Pediatric blood & cancer
Issue:
Volume 68:Issue 10(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. ACCELERATE – Five years accelerating cancer drug development for children and adolescents. (May 2022)

Authors:
Pearson, Andrew D.J.; Weiner, Susan L.; Adamson, Peter C.; Karres, Dominik; Reaman, Gregory; Rousseau, Raphaël; Blanc, Patricia; Norga, Koen; Skolnik, Jeffrey; Kearns, Pam; Scobie, Nicole; Barry, Elly; Marshall, Lynley V.; Knox, Leona; Caron, Hubert; Wariabharaj, Darshan; Pappo, Alberto; DuBois, ...
Journal:
European journal of cancer
Issue:
Volume 166(2022)
Page Start:
145
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies. (29th March 2018)

Authors:
Place, Andrew E; Goldsmith, Kelly; Bourquin, Jean-Pierre; Loh, Mignon L; Gore, Lia; Morgenstern, Daniel A; Sanzgiri, Yeshwant; Hoffman, David; Zhou, Ying; Ross, Jeremy A; Prine, Betty; Shebley, Mohamad; McNamee, Megan; Farazi, Thalia; Kim, Su Young; Verdugo, Maria; Lash-Fleming, Leanne; Zwaan, C ...
Journal:
Future oncology
Issue:
Volume 14:Number 21(2018)
Page Start:
2115
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL. Issue 9 (20th March 2022)

Authors:
Myers, Regina M.; Taraseviciute, Agne; Steinberg, Seth M.; Lamble, Adam J.; Sheppard, Jennifer; Yates, Bonnie; Kovach, Alexandra E.; Wood, Brent; Borowitz, Michael J.; Stetler-Stevenson, Maryalice; Yuan, Constance M.; Pillai, Vinodh; Foley, Toni; Chung, Perry; Chen, Lee; Lee, Daniel W.; Annesley,...
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 9(2022)
Page Start:
932
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗